DOCSLIB.ORG

Ambetter 90-Day-Maintenance Drug List- 2020

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ambetter 90-Day-Maintenance Drug List- 2020 Ambetter 90-Day-Maintenance Drug List Guide to this list: What is Ambetter 90‐Day‐Maintenance Drug List? Ambetter 90‐Day‐Supply Maintenance Drug List is a list of maintenance medications that are available for 90 day supply through mail order or through our Extended Day Supply Network. How do I find a pharmacy that is participating in Extended Day Supply Network? To find a retail pharmacy that is participating in our Extended Day Supply Network please consult information available under Pharmacy Resources tab on our webpage. Alternatively, you can utilize our mail order pharmacy. Information on mail order pharmacy is available in Pharmacy Resources tab on our webpage. Are all formulary drugs covered for 90 day supply? No, certain specialty and non‐specialty drugs are excluded from 90 day supply. Please consult 90‐Day‐ Supply Maintenance Drug List for information if your drug is included. A Amitriptyline HCl Acamprosate Calcium Amlodipine Besylate Acarbose Amlodipine Besylate-Atorvastatin Calcium Acebutolol HCl Amlodipine Besylate-Benazepril HCl Acetazolamide Amlodipine Besylate-Olmesartan Medoxomil Albuterol Sulfate Amlodipine Besylate-Valsartan Alendronate Sodium Amlodipine-Valsartan-Hydrochlorothiazide Alendronate Sodium-Cholecalciferol Amoxapine Alfuzosin HCl Amphetamine-Dextroamphetamine Aliskiren Fumarate Anagrelide HCl Allopurinol Anastrozole Alogliptin Benzoate Apixaban Alosetron HCl Arformoterol Tartrate Amantadine HCl Aripiprazole Amiloride & Hydrochlorothiazide Armodafinil Amiloride HCl Asenapine Maleate Amiodarone HCl Aspirin-Dipyridamole Inclusion of drugs on this list does not guarantee coverage. Please consult your benefit materials for further information. Ambetter from Meridian is underwritten by Meridian Health Plan of Michigan, Inc. © 2020 Meridian Health Plan of Michigan, Inc. All rights reserved. 1-833-993-2426 (TTY/TDD Relay 711) 1 Campus Martius, Suite 700 Detroit, MI 48226 AmbetterMeridian.com Atenolol Carbidopa-Levodopa-Entacapone Atenolol & Chlorthalidone Carteolol HCl (Ophth) Atomoxetine HCl Carvedilol Atorvastatin Calcium Celecoxib Auranofin Cevimeline HCl Azathioprine Chloroquine Phosphate Azilsartan Medoxomil Chlorothiazide Chlorpromazine HCl B Chlorpropamide Beclomethasone Dipropionate HFA Chlorthalidone Benazepril & Hydrochlorothiazide Cholestyramine Benazepril HCl Cholestyramine Light Benztropine Mesylate Cilostazol Betaxolol HCl Cimetidine Betaxolol HCl (Ophth) Cimetidine HCl Betrixaban Maleate Citalopram Hydrobromide Bimatoprost Clobazam Bisoprolol & Hydrochlorothiazide Clomipramine HCl Bisoprolol Fumarate Clonidine Brexpiprazole Clonidine HCl Brimonidine Tartrate Clonidine HCl (ADHD) Brimonidine Tartrate-Timolol Maleate Clopidogrel Bisulfate Brinzolamide-Brimonidine Tartrate Colchicine w/ Probenecid Brivaracetam Colesevelam HCl Bromocriptine Mesylate Colestipol HCl Bromocriptine Mesylate (Diabetes) Conjugated Estrogens-Bazedoxifene Budesonide (Inhalation) Conjugated Estrogens-Medroxyprogesterone Budesonide-Formoterol Fumarate Dihydrate Acetate Bumetanide Cromolyn Sodium Bupropion HCl Cyclosporine Cyclosporine (Ophth) C Cyclosporine Modified (For Microemulsion) Calcitonin (Salmon) Cysteamine Bitartrate Calcitriol Cysteamine HCl Calcium Acetate (Phosphate Binder) Candesartan Cilexetil D Candesartan Cilexetil-Hydrochlorothiazide Dapagliflozin Propanediol Cannabidiol Dapagliflozin-Metformin HCl Captopril Dapsone Carbamazepine Darifenacin Hydrobromide Carbamazepine (Antipsychotic) Deferiprone Carbidopa Desipramine HCl Carbidopa-Levodopa Desmopressin Acetate Inclusion of drugs on this list does not guarantee coverage. Please consult your benefit materials for further information. Ambetter from Meridian is underwritten by Meridian Health Plan of Michigan, Inc. © 2020 Meridian Health Plan of Michigan, Inc. All rights reserved. 1-833-993-2426 (TTY/TDD Relay 711) 1 Campus Martius, Suite 700 Detroit, MI 48226 AmbetterMeridian.com Desmopressin Acetate Spray Enalapril Maleate Desmopressin Acetate Spray Refrigerated Enalapril Maleate & Hydrochlorothiazide Desogestrel & Ethinyl Estradiol Entacapone Desogestrel-Ethinyl Estradiol (Biphasic) Eplerenone Desogestrel-Ethinyl Estradiol (Triphasic) Eprosartan Mesylate Desvenlafaxine Succinate Erenumab-aooe Dexlansoprazole Ergocalciferol Dexmethylphenidate HCl Ergoloid Mesylates Dextroamphetamine Sulfate Ertugliflozin L-Pyroglutamic Acid Dextromethorphan HBr-Quinidine Sulfate Ertugliflozin-Metformin HCl Diazoxide Escitalopram Oxalate Diclofenac Potassium Eslicarbazepine Acetate Diclofenac Sodium Esomeprazole Magnesium Diclofenac w/ Misoprostol Esterified Estrogens Diflunisal Estradiol Digoxin Estradiol Acetate Vaginal Diltiazem HCl Estradiol Vaginal Diltiazem HCl Coated Beads Estradiol Valerate-Dienogest Diltiazem HCl Extended Release Beads Estradiol-Levonorgestrel Dipyridamole Estrogens, Conjugated Disopyramide Phosphate Estrogens, Conjugated Vaginal Disulfiram Ethacrynic Acid Divalproex Sodium Ethosuximide Dofetilide Ethotoin Donepezil Hydrochloride Ethynodiol Diacet & Eth Estrad Dorzolamide HCl Etodolac Dorzolamide HCl-Timolol Maleate Etonogestrel-Ethinyl Estradiol Doxazosin Mesylate Ezetimibe Doxepin HCl Ezetimibe-Simvastatin Doxercalciferol Dronedarone HCl F Drospirenone Famotidine Drospirenone-Ethinyl Estradiol Febuxostat Drospirenone-Ethinyl Estradiol-Levomefolate Felbamate Calcium Felodipine Dulaglutide Fenofibrate Duloxetine HCl Fenofibrate Micronized Dutasteride Fenoprofen Calcium Fesoterodine Fumarate E Finasteride Echothiophate Iodide Flavoxate HCl Empagliflozin Flecainide Acetate Empagliflozin-Metformin HCl Fludrocortisone Acetate Inclusion of drugs on this list does not guarantee coverage. Please consult your benefit materials for further information. Ambetter from Meridian is underwritten by Meridian Health Plan of Michigan, Inc. © 2020 Meridian Health Plan of Michigan, Inc. All rights reserved. 1-833-993-2426 (TTY/TDD Relay 711) 1 Campus Martius, Suite 700 Detroit, MI 48226 AmbetterMeridian.com Fluoxetine HCl Ibandronate Sodium Fluoxetine HCl (PMDD) Ibuprofen Fluphenazine HCl Icosapent Ethyl Flurbiprofen Imipramine HCl Fluticasone Furoate (Inhalation) Imipramine Pamoate Fluticasone Furoate-Vilanterol Indacaterol Maleate Fluticasone Propionate (Inhalation) Indacaterol Maleate-Glycopyrrolate Fluticasone Propionate HFA Indapamide Fluticasone-Salmeterol Indomethacin Fluticasone-Umeclidinium-Vilanterol Insulin Aspart Fluvastatin Sodium Insulin Aspart (with Niacinamide) Fluvoxamine Maleate Insulin Aspart Protamine & Aspart (Human) Folic Acid Insulin Degludec Fosinopril Sodium Insulin Degludec-Liraglutide Fosinopril Sodium & Hydrochlorothiazide Insulin Detemir Furosemide Insulin Glargine Insulin NPH (Human) (Isophane) G Insulin NPH Isophane & Reg (Human) Gabapentin Insulin Regular (Human) Gabapentin Enacarbil Ipratropium Bromide Galantamine Hydrobromide Ipratropium Bromide (Nasal) Galcanezumab-gnlm Ipratropium Bromide HFA Gemfibrozil Ipratropium-Albuterol Glatiramer Acetate Irbesartan Glimepiride Irbesartan-Hydrochlorothiazide Glipizide Isocarboxazid Glipizide-Metformin HCl Isoniazid Glyburide Isosorbide Dinitrate Glyburide Micronized Isosorbide Dinitrate-Hydralazine HCl Glyburide-Metformin Isosorbide Mononitrate Glycopyrrolate-Formoterol Fumarate Isradipine Guanfacine HCl Ivabradine HCl Guanfacine HCl (ADHD) K H Ketoprofen Haloperidol Haloperidol Lactate L Hydralazine HCl Labetalol HCl Hydrochlorothiazide Lacosamide Hydroxychloroquine Sulfate Lactulose Hydroxyurea (Sickle Cell Anemia) Lactulose (Encephalopathy) Lamivudine (HBV) I Lamotrigine Inclusion of drugs on this list does not guarantee coverage. Please consult your benefit materials for further information. Ambetter from Meridian is underwritten by Meridian Health Plan of Michigan, Inc. © 2020 Meridian Health Plan of Michigan, Inc. All rights reserved. 1-833-993-2426 (TTY/TDD Relay 711) 1 Campus Martius, Suite 700 Detroit, MI 48226 AmbetterMeridian.com Lansoprazole Meloxicam Lanthanum Carbonate Memantine HCl Latanoprost Mesalamine Leflunomide Metaproterenol Sulfate Lesinurad Metformin HCl Lesinurad-Allopurinol Methamphetamine HCl Letrozole Methazolamide Levalbuterol HCl Methimazole Levalbuterol Tartrate Methsuximide Levetiracetam Methyclothiazide Levobunolol HCl Methyldopa Levomilnacipran HCl Methylphenidate Levonorgestrel & Eth Estradiol Methylphenidate HCl Levonorgestrel-Eth Estradiol (Triphasic) Methyltestosterone Levonorgestrel-Ethinyl Estradiol & Folic Acid Metolazone Levonorgestrel-Ethinyl Estradiol (91-Day) Metoprolol & Hydrochlorothiazide Levonorgestrel-Ethinyl Estradiol (Continuous) Metoprolol Succinate Levonorgestrel-Ethinyl Estradiol-Ferrous Metoprolol Tartrate Bisglycinate Mexiletine HCl Levothyroxine Sodium Miglitol Linaclotide Milnacipran HCl Liothyronine Sodium Minoxidil Liraglutide Mirabegron Lisdexamfetamine Dimesylate Mirtazapine Lisinopril Misoprostol Lisinopril & Hydrochlorothiazide Modafinil Lithium Moexipril HCl Lithium Carbonate Montelukast Sodium Losartan Potassium Mycophenolate Mofetil Losartan Potassium & Hydrochlorothiazide Mycophenolate Sodium Lovastatin Loxapine Succinate N Lubiprostone Nabumetone Lurasidone HCl Nadolol Naproxen M Naproxen Sodium Maprotiline HCl Nateglinide Mecamylamine HCl Nebivolol HCl Meclofenamate Sodium Nefazodone HCl Medroxyprogesterone Acetate Niacin (Antihyperlipidemic) Mefenamic Acid Niacin-Lovastatin Mefloquine HCl Niacin-Simvastatin Megestrol Acetate (Appetite) Nicardipine HCl Inclusion of drugs on this list does not guarantee coverage. Please consult your benefit materials for further information. Ambetter from Meridian is underwritten
Load more

Recommended publications
  • SPIRONOLACTONE Spironolactone – Oral (Common Brand Name
    SPIRONOLACTONE Spironolactone – oral (common brand name: Aldactone) Uses: Spironolactone is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat swelling (edema) caused by certain conditions (e.g., congestive heart failure) by removing excess fluid and improving symptoms such as breathing problems. This medication is also used to treat low potassium levels and conditions in which the body is making too much of a natural chemical (aldosterone). Spironolactone is known as a “water pill” (potassium-sparing diuretic). Other uses: This medication has also been used to treat acne in women, female pattern hair loss, and excessive hair growth (hirsutism), especially in women with polycystic ovary disease. Side effects: Drowsiness, lightheadedness, stomach upset, diarrhea, nausea, vomiting, or headache may occur. To minimize lightheadedness, get up slowly when rising from a seated or lying position. If any of these effects persist or worsen, notify your doctor promptly. Tell your doctor immediately if any of these unlikely but serious side effects occur; dizziness, increased thirst, change in the amount of urine, mental/mood chances, unusual fatigue/weakness, muscle spasms, menstrual period changes, sexual function problems. This medication may lead to high levels of potassium, especially in patients with kidney problems. If not treated, very high potassium levels can be fatal. Tell your doctor immediately if you notice any of the following unlikely but serious side effects: slow/irregular heartbeat, muscle weakness. Precautions: Before taking spironolactone, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies.
    [Show full text]
  • 2020 Prior Authorization Criteria
    2020 PRIOR AUTHORIZATION CRITERIA TABLE OF CONTENTS abiraterone tablet ...................................................................................................................... 217 ABRAXANE .............................................................................................................................. 131 ACTIMMUNE .............................................................................................................................. 14 ADASUVE ................................................................................................................................... 27 ADEMPAS ................................................................................................................................ 197 AFINITOR ................................................................................................................................. 217 AFINITOR DISPERZ ................................................................................................................. 217 AIMOVIG ..................................................................................................................................... 15 ALECENSA ............................................................................................................................... 217 ALIMTA ..................................................................................................................................... 131 ALIQOPA .................................................................................................................................
    [Show full text]
  • An Approach to the Patient with a Dry Mouth
    MedicineToday 2014; 15(4): 30-37 PEER REVIEWED FEATURE 2 CPD POINTS An approach to the patient with a dry mouth Key points • The subjective complaint of ELHAM AFLAKI MD; TAHEREH ERFANI MD; NICHOLAS MANOLIOS MB BS(Hons), PhD, MD, FRACP, FRCPA; xerostomia needs to be MARK SCHIFTER FFD, RCSI(Oral Med), FRACDS(Oral Med) differentiated from true salivary hypofunction. Dry mouth is a common and disabling problem. After exclusion of treatable • Salivary hypofunction can significantly reduce quality causes, treatment is symptomatic to prevent the consequences of salivary of life through its adverse hypofunction, such as tooth decay and infection of the oral mucosa. effects on taste, mastication, swallowing, cleansing of the erostomia, or the subjective feeling of neuropathic-induced orofacial dysaesthesia) mouth, killing of microbes a dry mouth, is a common complaint. and psychological and psychiatric disorders, and speech. It is often a consequence of salivary such as anxiety and depression. • Salivary hypofunction is a hypofunction (hyposalivation), in substantive risk factor for X which there is objective evidence of reduced NORMAL SALIVA PRODUCTION dental caries, oral mucosal salivary output or qualitative changes in saliva. Under normal physiological conditions, the disease and infection, Typically, patients complain of oral dryness salivary glands produce 1000 to 1500 mL of particularly oral candidiasis. only when salivary secretion is reduced by more saliva daily as an ultrafiltrate from the circu- • Patients should be than half.1 As saliva has a crucial role in taste lating plasma. Therefore, simple dehydration investigated for contributory perception, mastication, swallowing, cleansing reduces saliva production. The parotid glands and underlying causes, of the mouth, killing of microbes and speech, are the major source of serous saliva (60 to 65% which include drugs and abnormalities in saliva production can signif- of total saliva volume), producing the stimu- rheumatological diseases.
    [Show full text]
  • Optum Essential Health Benefits Enhanced Formulary PDL January
    PENICILLINS ketorolac tromethamineQL GENERIC mefenamic acid amoxicillin/clavulanate potassium nabumetone amoxicillin/clavulanate potassium ER naproxen January 2016 ampicillin naproxen sodium ampicillin sodium naproxen sodium CR ESSENTIAL HEALTH BENEFITS ampicillin-sulbactam naproxen sodium ER ENHANCED PREFERRED DRUG LIST nafcillin sodium naproxen DR The Optum Preferred Drug List is a guide identifying oxacillin sodium oxaprozin preferred brand-name medicines within select penicillin G potassium piroxicam therapeutic categories. The Preferred Drug List may piperacillin sodium/ tazobactam sulindac not include all drugs covered by your prescription sodium tolmetin sodium drug benefit. Generic medicines are available within many of the therapeutic categories listed, in addition piperacillin sodium/tazobactam Fenoprofen Calcium sodium to categories not listed, and should be considered Meclofenamate Sodium piperacillin/tazobactam as the first line of prescribing. Tolmetin Sodium Amoxicillin/Clavulanate Potassium LOW COST GENERIC PREFERRED For benefit coverage or restrictions please check indomethacin your benefit plan document(s). This listing is revised Augmentin meloxicam periodically as new drugs and new prescribing LOW COST GENERIC naproxen kit information becomes available. It is recommended amoxicillin that you bring this list of medications when you or a dicloxacillin sodium CARDIOVASCULAR covered family member sees a physician or other penicillin v potassium ACE-INHIBITORS healthcare provider. GENERIC QUINOLONES captopril ANTI-INFECTIVES
    [Show full text]
  • Diabetes Medications: Oral Medications
    Diabetes Medications: Oral Medications Medication Types 1. Biguanides 2. Sulfonylureas 3. Thiazolidinediones (TZDs) 4. Alpha-Glucosidase Inhibitors 5. D-Phenylalanine Meglitinides 6. SGLT-2 inhibitors 7. DPP-4 inhibitors 8. Combination Oral Medications 1. Biguanides This works by lowering blood glucose by reducing the amount of glucose produced by the liver and helping the body respond better to the insulin made in the pancreas Metformin can be used with diet and exercise or with other agents, diet, and exercise. Types of Biguanides: • Metformin (Glucophage) 500mg/1000mg • Metformin (Glucophage XR) 500mg/1000mg • Fortamet (extended release) 500mg/1000mg • Riomet (oral solution) 500mg/5ml Side Effects: • Cramping • Gas • Diarrhea • Taking the pill before meals may decrease stomach upset 2. Sulfonylureas Sulfonylureas stimulate the pancreas to produce insulin and cause the body to respond better to the insulin it does produce. Sulfonylureas can be used alone or in combination with other medications. Types of Sulfonylureas: • Glimepiride (Amaryl) • Glipizide (Glucotrol, Glucotrol XL) • Glyburide (Diabeta, Micronase) • Glyburide, micronized (Glynase) • Tolbutamide (Orinase) 1st generation • Tolazamide (Tolinase) 1st generation • Acetohexamide (Dymelor) 1st generation • Chlorpropamide (Diabinese) 1st generation Side Effects: • Hypoglycemia • Upset stomach • Weight gain • Skin rash 3. Thiazolidinediones (TZDs) TZDs primarily reduce insulin resistance by improving target cell response (sensitivity) to insulin. They also can decrease glucose output from the liver and increase glucose disposal in the skeletal muscles. Types of TZDs: • Pioglitazione (Actos) 15-45 mg Actos may be taken with or without food • Avandia—off the market Side Effects: • Jaundice • Nausea and vomiting • Stomach pain • Dark urine • Swelling • These medicines are generally safe and do not cause hypoglycemia when used alone.
    [Show full text]
  • Neurontin (Gabapentin)
    Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Gabapentin Clinical Criteria Information Included in this Document Neurontin (gabapentin) • Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria • Prior authorization criteria logic: a description of how the prior authorization request will be evaluated against the clinical criteria rules • Logic diagram: a visual depiction of the clinical criteria logic • Supporting tables: a collection of information associated with the steps within the criteria (diagnosis codes, procedure codes, and therapy codes); provided when applicable • References: clinical publications and sources relevant to this clinical criteria Note: Click the hyperlink to navigate directly to that section. Gralise (gabapentin Extended Release) • Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria • Prior authorization criteria logic: a description of how the prior authorization request will be evaluated against the clinical criteria rules • Logic diagram: a visual depiction of the clinical criteria logic • Supporting tables: a collection of information associated with the steps within the criteria (diagnosis codes, procedure codes, and therapy codes); provided when applicable • References: clinical publications and sources relevant to this clinical criteria Note: Click the hyperlink to navigate directly to that section. March 29, 2019 Copyright © 2019 Health Information Designs, LLC 1 Horizant
    [Show full text]
  • Topically Applied Minoxidil in Baldness
    Review Topically Applied Minoxidil in Baldness ERVIN NOVAK,M.D., THOMASJ. FRANZ, M.D., JOHN T. HEADINGTON,M.D., AND RONALD C. WESTER,PH.D. From the Upjohn Company, Kalamazoo, Michigan, School idil and its metabolites can be removed by hemodi- of Medicine, University of Washington, Seattle, alysis. Washington, Medical School, University of Michigan, Ann Fluid retention and hypertrichosis are the most Arbor, Michigan, and School of Medicine and School of Pharmacy, University of California, San Francisco, California commonly occurring side effects of minoxidil. Hair regrowth in a patient with male pattern baldness was described in a case report of a hypertensive patient treated twice daily with 20 mg oral minoxidil.6 The Minoxidil, an orally administered, peripheral va- extensive hair regrowth continued after 10 months sodilator used to treat hypertension, causes hypertri- of therapy. New and increased hair growth as a side chosis in more than 80% of users. The drug reduces effect was also detected in an early clinical study elevated blood pressure by decreasing peripheral involving five of eight patients on oral minoxidil vascular resistance. Chemically, minoxidil is 2,4-di- therapy for 2 month^.^ Zappacosta' reported reversal amino-6-piperidinopyrimidine-3-oxide; it is soluble in of baldness in a patient on minoxidil for the treatment water to the extent of approximately 2 mg/ml, is of hypertension. more readily soluble in propylene glycol or ethanol, After the third week of therapy with oral minoxidil, and is nearly insoluble in acetone, chloroform, or hypertrichosis usually appears between the eyebrows ethyl acetate. Following oral administration of minox- and the hair line, in the malar and temporal areas, idil and in association with the reduction in peripheral on the backs of the arms, on the shoulders, and on vascular resistance, cardiac output is augmented, salt the legs.
    [Show full text]
  • Orange Book Patent Listing Dispute List
    Patent Listing Disputes Current through September 10, 2021 Established Drug Product Due Date for NDA Holder NDA Holder NDA Number NDA Holder Strength(s) Relevant U.S. Patent Number(s) Type of Patent Claim Original Use Code (if applicable) Revised Use Code (if applicable) Dispute Outcome Name Response Response Date Disputes Not Related to epinephrine 205029 Belcher 1mg/mL 10,004,700 and 10,039,728 N/A N/A 7/24/2021 Pending Pending Use Code 7 mg 14 mg 8,168,209, 8,173,708, 8,283,379, Disputes Not Related to memantine hydrochloride 22525 Allergan Sales LLC N/A N/A 5/28/2021 5/28/2021 Patent Listing Updated 21 mg 8,329,752, 8,362,085 and 8,598,233 Use Code 28 mg 0.1 mg Disputes Not Related to epinephrine 201739 Kaleo Inc 0.15 mg 10,824,938 N/A N/A 2/28/2021 2/3/2021 Patent Listing Updated Use Code 0.3 mg Disputes Not Related to netarsudil and latanoprost 208259 Aerie Pharms Inc 0.02%/0.005% 10,654,844 N/A N/A 11/18/2020 10/30/2020 Patent Listing Updated Use Code Disputes Not Related to netarsudil 208254 Aerie Pharms Inc 0.02% 10,654,844 N/A N/A 11/18/2020 10/30/2020 Patent Listing Updated Use Code U-2869: IV Administration of cangrelor before U-2979: Method comprising IV administration PCI and continuous infusion for at least 2 of cangrelor before PCI then continuous hours or the duration of the PCI and, during infusion for at least 2 hours or the duration of cangrelor 204958 Chiesi 50 mg/vial 8,680,052 Method of Use 11/8/2020 11/3/2020 Patent Listing Updated or after the continuous infusion, PCI and, during or after continuous infusion,
    [Show full text]
  • M2021: Pharmacogenetic Testing
    Pharmacogenetic Testing Policy Number: AHS – M2021 – Pharmacogenetic Prior Policy Name and Number, as applicable: Testing • M2021 – Cytochrome P450 Initial Presentation Date: 06/16/2021 Revision Date: N/A I. Policy Description Pharmacogenetics is defined as the study of variability in drug response due to heredity (Nebert, 1999). Cytochrome (CYP) P450 enzymes are a class of enzymes essential in the synthesis and breakdown metabolism of various molecules and chemicals. Found primarily in the liver, these enzymes are also essential for the metabolism of many medications. CYP P450 are essential to produce many biochemical building blocks, such as cholesterol, fatty acids, and bile acids. Additional cytochrome P450 are involved in the metabolism of drugs, carcinogens, and internal substances, such as toxins formed within cells. Mutations in CYP P450 genes can result in the inability to properly metabolize medications and other substances, leading to increased levels of toxic substances in the body. Approximately 58 CYP genes are in humans (Bains, 2013; Tantisira & Weiss, 2019). Thiopurine methyltransferase (TPMT) is an enzyme that methylates azathioprine, mercaptopurine and thioguanine into active thioguanine nucleotide metabolites. Azathioprine and mercaptopurine are used for treatment of nonmalignant immunologic disorders; mercaptopurine is used for treatment of lymphoid malignancies; and thioguanine is used for treatment of myeloid leukemias (Relling et al., 2011). Dihydropyrimidine dehydrogenase (DPD), encoded by the gene DPYD, is a rate-limiting enzyme responsible for fluoropyrimidine catabolism. The fluoropyrimidines (5-fluorouracil and capecitabine) are drugs used in the treatment of solid tumors, such as colorectal, breast, and aerodigestive tract tumors (Amstutz et al., 2018). A variety of cell surface proteins, such as antigen-presenting molecules and other proteins, are encoded by the human leukocyte antigen genes (HLAs).
    [Show full text]
  • Estradiol Acetate Vaginal Ring) Rx Only
    NDA 21-367/S-002 Page 3 PRESCRIBING INFORMATION Femring® (estradiol acetate vaginal ring) Rx Only ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER Close clinical surveillance of all women taking estrogens is important. Adequate diagnostic measures, including endometrial sampling when indicated, should be undertaken to rule out malignancy in all cases of undiagnosed persistent or recurring abnormal vaginal bleeding. There is no evidence that the use of “natural” estrogens results in a different endometrial risk profile than synthetic estrogens at equivalent estrogen doses. (See WARNINGS, Malignant neoplasms, Endometrial cancer.) CARDIOVASCULAR AND OTHER RISKS Estrogens with or without progestins should not be used for the prevention of cardiovascular disease or dementia. (See WARNINGS, Cardiovascular disorders and Dementia.) The Women’s Health Initiative (WHI) study reported increased risks of myocardial infarction, stroke, invasive breast cancer, pulmonary emboli, and deep vein thrombosis in postmenopausal women (50 to 79 years of age) during 5 years of treatment with oral conjugated estrogens (CE 0.625 mg) combined with medroxyprogesterone acetate (MPA 2.5 mg) relative to placebo. (See CLINICAL PHARMACOLOGY, Clinical Studies and WARNINGS, Cardiovascular disorders and Malignant neoplasms, Breast cancer.) The Women’s Health Initiative Memory Study (WHIMS), a substudy of WHI, reported increased risk of developing probable dementia in postmenopausal women 65 years of age or older during 4 years of treatment with oral conjugated estrogens
    [Show full text]
  • Pilocarpine (Systemic) | Memorial Sloan Kettering Cancer Center
    PATIENT & CAREGIVER EDUCATION Pilocarpine (Systemic) This information from Lexicomp® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider. Brand Names: US Salagen Brand Names: Canada JAMP Pilocarpine; M-Pilocarpine; Salagen What is this drug used for? It is used to treat dry mouth. What do I need to tell my doctor BEFORE I take this drug? If you have an allergy to pilocarpine or any other part of this drug. If you are allergic to this drug; any part of this drug; or any other drugs, foods, or substances. Tell your doctor about the allergy and what signs you had. If you have any of these health problems: Asthma, glaucoma, liver disease, or swelling in parts of the eye. If you are breast-feeding or plan to breast-feed. This is not a list of all drugs or health problems that interact with this drug. Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure Pilocarpine (Systemic) 1/6 that it is safe for you to take this drug with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor. What are some things I need to know or do while I take this drug? Tell all of your health care providers that you take this drug. This includes your doctors, nurses, pharmacists, and dentists.
    [Show full text]
  • Medication Choice Diabetes
    Weight Change Low Blood Sugar Blood Sugar Considerations (Hypoglycemia) Blood(A1c Reduction) Sugar Weight Change Low Blood Sugar (A1c Reduction) Considerations (Hypoglycemia) Metformin Metformin Metformin 1 – 2% Metformin In the rst few weeks after starting Metformin, patients may have some nausea, indigestion or diarrhea. None No Severe Risk Minor = 0 – 1% Insulin There are no other side effects associated with Insulin. Insulin Insulin Insulin Unlimited % Pioglitazone 4 to 6 lb. gain Over time, 10 in 100 people may have fluid retention Severe = 1 – 3% Minor = 30 – 40% (edema) while taking the drug. For some it may be as little as ankle swelling. For others, fluid may build up Pioglitazone 1% in the lungs making it difficult to breathe. This may Pioglitazone Pioglitazone resolve after you stop taking the drug. 10 in 100 people at risk of bone fractures who use this drug will have More than 2 to 6 lb. gain a bone fracture in the next 10 years. There appears to No Severe Risk Minor = 1 – 2% be a slight increase in the risk of bladder cancer with Liraglutide/ 0.5 – 1% this drug. Liraglutide/Exenatide Liraglutide/Exenatide Exenatide Liraglutide/Exenatide Some patients may have nausea or diarrhea. In some 3 to 6 lb. loss cases, the nausea may be severe enough that a patient No Severe Risk Minor = 0 – 1% has to stop taking the drug. There are reports of pain in the abdomen that may be caused by inammation Sulfonylureas Sulfonylureas Sulfonylureas 1 – 2% of the pancreas with these agents. Glipizide, Glimepiride, Glyburide Glipizide, Glimepiride, Glyburide Glipizide, Glimepiride, Glyburide Sulfonylureas 2 to 3 lb.
    [Show full text]